User profiles for Nicolaus Schwerk

nicolaus schwerk

Facharzt für Kinder und Jugendmedizin
Verified email at mh-hannover.de
Cited by 5450

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study

…, S Thee, R Kobbe, C Rau, N Schwerk… - The Lancet Child & …, 2020 - thelancet.com
Background To date, few data on paediatric COVID-19 have been published, and most reports
originate from China. This study aimed to capture key data on children and adolescents …

Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k guideline of the German society for allergology and clinical immunology (DGAKI …

…, A Schuster, N Schwerk… - Allergo journal …, 2014 - Springer
The present guideline (S2k) on allergen-specific immunotherapy (AIT) was established by
the German, Austrian and Swiss professional associations for allergy in consensus with the …

European protocols for the diagnosis and initial treatment of interstitial lung disease in children

…, AG Nicholson, M Wetzke, D Snijders, N Schwerk… - Thorax, 2015 - thorax.bmj.com
Interstitial lung disease in children (chILD) is rare, and most centres will only see a few
cases/year. There are numerous possible underlying diagnoses, with specific and non-specific …

Provoking allergens and treatment of anaphylaxis in children and adolescents–data from the anaphylaxis registry of German‐speaking countries

…, T Reese, Z Szepfalusi, N Schwerk… - Pediatric allergy and …, 2011 - Wiley Online Library
To cite this article: Hompes S, Köhli A, Nemat K, Scherer K, Lange L, Rueff F, Rietschel E,
Reese T, Szepfalusi Z, Schwerk N, Beyer K, Hawranek T, Niggemann B, Worm M. Provoking …

[PDF][PDF] ZMYND10 is mutated in primary ciliary dyskinesia and interacts with LRRC6

…, K Landwehr, K Nielsen, N Schwerk… - The American Journal of …, 2013 - cell.com
Defects of motile cilia cause primary ciliary dyskinesia (PCD), characterized by recurrent
respiratory infections and male infertility. Using whole-exome resequencing and high-…

Lung transplantation for severe pulmonary hypertension—awake extracorporeal membrane oxygenation for postoperative left ventricular remodelling

…, J Hadem, T Fühner, F Ius, M Avsar, N Schwerk… - …, 2015 - journals.lww.com
Background Bilateral lung transplantation (BLTx) is an established treatment for end-stage
pulmonary hypertension (PH). Ventilator weaning failure and death are more common as in …

Lung disease caused by ABCA3 mutations

…, N Regamey, E Eber, J Seidenberg, N Schwerk… - Thorax, 2017 - thorax.bmj.com
Background Knowledge about the clinical spectrum of lung disease caused by variations in
the ATP binding cassette subfamily A member 3 (ABCA3) gene is limited. Here we describe …

Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis

…, C Hennig, T Rodt, JP Bankstahl, N Schwerk… - Science translational …, 2014 - science.org
Hereditary pulmonary alveolar proteinosis (herPAP) is a rare lung disease caused by
mutations in the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor genes, …

[HTML][HTML] Nintedanib in children and adolescents with fibrosing interstitial lung diseases

…, S Cunningham, N Schwerk… - European …, 2023 - Eur Respiratory Soc
Background Childhood interstitial lung disease (ILD) comprises a spectrum of rare ILDs
affecting infants, children and adolescents. Nintedanib is a licensed treatment for pulmonary …

Five-year experience with intraoperative extracorporeal membrane oxygenation in lung transplantation: Indications and midterm results

…, J Puntigam, J Optenhoefel, M Greer, N Schwerk… - The Journal of Heart and …, 2016 - Elsevier
Background Since April 2010, extracorporeal membrane oxygenation (ECMO) has replaced
cardiopulmonary bypass for intraoperative support during lung transplantation at our …